Nuclea Biotechnologies Initiates Series C Round Targeting $10M
April 13, 2012
Nuclea Biotechnologies Initiates Series C Round Targeting $10M
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Nuclea Files for FDA Approval of Breast Cancer, Prostate Cancer Assays
January 12, 2012 / GenomeWeb Daily News - With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise
May 8, 2013 / Pharmacogenomics Reporter - Genomics in the Journals
April 4, 2013 / GenomeWeb Daily News - Nuclea Biotechnologies Raises $1.1M Toward $2.5M Financing Round
February 22, 2013 / GenomeWeb Daily News - Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News